In agreement with these findings, the results of the CCK‐8 assay showed that downregulation of BACE2 suppressed the proliferation of glioma cells, while BACE2 overexpression promoted cell proliferation (Fig. 4C,D). Here, BACE2 is linked to central nervous system cancer.